We are live on ! Find out more
CLMT icon

Calumet Specialty Products

69 hedge funds and large institutions have $383M invested in Calumet Specialty Products in 2024 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 26 increasing their positions, 12 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

117% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 12

13% more capital invested

Capital invested by funds: $338M → $383M (+$44.7M)

1.31% more ownership

Funds ownership: 28.33%29.64% (+1.3%)

12% less funds holding

Funds holding: 7869 (-9)

17% less funds holding in top 10

Funds holding in top 10: 65 (-1)

38% less call options, than puts

Call options by funds: $16.3M | Put options by funds: $26.4M

50% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 18

Holders
69
Holders Change
-9
Holders Change %
-11.54%
% of All Funds
1%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.07%
New
9
Increased
26
Reduced
12
Closed
18
Calls
$16.3M
Puts
$26.4M
Net Calls
-$10M
Net Calls Change
+$10.5M
Name Holding Trade Value Shares
Change
Change in
Stake
WDOM
1
Wasserstein Debt Opportunities Management
New York
$111M +$3.05M +193,063 +3%
AAA
2
Adams Asset Advisors
Texas
$84.3M -$3.15M -199,431 -4%
DMKJ
3
David M. Knott Jr
$69.4M
Goldman Sachs
4
Goldman Sachs
New York
$10.4M +$1.08M +68,619 +12%
RJA
5
Raymond James & Associates
Florida
$9.18M +$1.07M +67,689 +13%
GC
6
Grizzlyrock Capital
Illinois
$8.63M +$268K +17,000 +3%
Susquehanna International Group
7
Susquehanna International Group
Pennsylvania
$7.9M +$1.96M +124,452 +34%
Corient Private Wealth
8
Corient Private Wealth
Florida
$7.44M -$260K -16,465 -3%
Morgan Stanley
9
Morgan Stanley
New York
$7.16M +$1.47M +93,218 +26%
Group One Trading
10
Group One Trading
Illinois
$6.5M +$223K +14,157 +4%
BCM
11
Bienville Capital Management
New York
$5.47M
Royal Bank of Canada
12
Royal Bank of Canada
Ontario, Canada
$5.12M +$40.6K +2,573 +0.8%
UBS Group
13
UBS Group
Switzerland
$4.92M +$2.5M +158,517 +107%
BC
14
Barnett & Company
Tennessee
$4.52M -$31.6K -2,000 -0.7%
IG
15
ING Group
Netherlands
$4.16M +$600K +38,000 +17%
LPL Financial
16
LPL Financial
California
$3.1M +$372K +23,582 +14%
Brown Advisory
17
Brown Advisory
Maryland
$2.98M
Bank of America
18
Bank of America
North Carolina
$2.56M +$2.18M +138,401 +664%
Citadel Advisors
19
Citadel Advisors
Florida
$2.22M +$1.67M +105,902 +324%
Simplex Trading
20
Simplex Trading
Illinois
$2.04M +$1.66M +104,948 +477%
CM
21
Caption Management
Oklahoma
$1.99M +$1.96M +123,889 New
LW
22
Linscomb Wealth
Texas
$1.78M
Citigroup
23
Citigroup
New York
$1.65M +$282K +17,859 +21%
SA
24
Sanctuary Advisors
Indiana
$1.26M +$1.28M +81,137 New
ECP
25
Epacria Capital Partners
Colorado
$1.22M -$23K -1,454 -2%

CLMT Hedge Fund Activity: Q2 2024 in Review

69 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Calumet Specialty Products (CLMT) for Q2 2024, worth a combined $383M — up 13% from $338M a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of CLMT and 9 opened new positions — a net loss of 9 holders — while 12 trimmed existing stakes and 26 added.

The largest buyer was Wasserstein Debt Opportunities Management, adding an estimated $3.05M. The largest seller was Adams Asset Advisors, cutting an estimated $3.15M.

  • 69 institutional investors held Calumet Specialty Products (CLMT) as of Q2 2024, down from 78 in Q1 2024.
  • Funds reported $383M of Calumet Specialty Products stock for Q2 2024, up 13% quarter-over-quarter.
  • 9 funds opened new Calumet Specialty Products positions in Q2 2024 and 18 closed out, a net change of -9 holders.
  • The largest Calumet Specialty Products buyer in Q2 2024 was Wasserstein Debt Opportunities Management, an estimated $3.05M added.
  • The largest Calumet Specialty Products seller in Q2 2024 was Adams Asset Advisors, an estimated $3.15M sold.

Based on aggregated 13F filings for Q2 2024.